Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer

Zornica V. Gorcheva

doi:10.2478/jbcr-2022-0016

Abstract

Gastric cancer is the fifth most common and third leading cause of cancer death worldwide. Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at increased risk of developing gastric cancer (GC). It is common for CAG to precede IM, but the etiology of the two conditions is not always the same. Different scoring systems are used to assess HAG, MI, and GC risk, making it difficult to interpret results from investigations and management of these conditions.

References

1. Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut. 2000 Nov 1;47(5):618–21.10.1136/gut.47.5.618172811411034575
Search in Google Scholar Back to article
2. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. А model for Gastric Cancer Epidemiology. The Lancet. 1975;306(7924):58–60.10.1016/S0140-6736(75)90498-5
Search in Google Scholar Back to article
3. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9.10.1111/j.1751-2980.2011.00550.x340460022188910
Search in Google Scholar Back to article
4. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.10.1111/apm.1965.64.1.3114320675
Search in Google Scholar Back to article
5. Huang YK, Yu JC, Kang WM, Ma ZQ, Ye X, Tian SB, et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis. PloS One. 2015 Nov 10;10(11):e0142080.10.1371/journal.pone.0142080464055526556485
Search in Google Scholar Back to article
6. Schindler R. Chronic gastritis. Bulletin of the New York Academy of Medicine. 1939 May;15(5):322
Search in Google Scholar Back to article
7. Whitehead R, Truelove SC, Gear MW. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol. 1972;25(1):1–11.10.1136/jcp.25.1.14772135015372
Search in Google Scholar Back to article
8. Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18(5):426–40.10.1007/BF010719954573514
Search in Google Scholar Back to article
9. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model. Gastroenterology. 1997;113(6):1983–91.10.1016/S0016-5085(97)70019-29394739
Search in Google Scholar Back to article
10. Dixon MF, Genta RM, Yardley JH, Correa P, Batts KP, Dahms BB, et al. Classification and grading of Gastritis: The updated Sydney system. Am J Surg Pathol. 1996 Oct;20(10):1161–81.10.1097/00000478-199610000-000018827022
Search in Google Scholar Back to article
11. Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: The OLGA staging system. Gut. 2007;56(5):631–6.10.1136/gut.2006.106666194214317142647
Search in Google Scholar Back to article
12. Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K, et al. Gastritis staging: Interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch. 2014;464(4):403–7.10.1007/s00428-014-1544-324477629
Search in Google Scholar Back to article
13. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology. 1994;25(4).10.1111/j.1365-2559.1994.tb01349.x7835836
Search in Google Scholar Back to article
14. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: Interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002;16(7):1249–59.10.1046/j.1365-2036.2002.01301.x12144574
Search in Google Scholar Back to article
15. Gonzalez RS, Raza A, Propst R, Adeyi O, Bateman J, Sopha SC, et al. Recent advances in digestive tract tumors: updates from the 5th edition of the World Health Organization “Blue Book.” Archives of Pathology and Laboratory Medicine. 2021;145(5): 607–62610.5858/arpa.2020-0047-RA32886739
Search in Google Scholar Back to article
16. Jass JR, Filipe MI. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology. 1979;3(3).10.1111/j.1365-2559.1979.tb02996.x468122
Search in Google Scholar Back to article
17. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human Pathology 2005;36(3):228–33.10.1016/j.humpath.2004.12.00815791566
Search in Google Scholar Back to article
18. Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: Pathologist’s viewpoint. World J Gastroenterol. 2015;21(42):12179–89.10.3748/wjg.v21.i42.12179464113526576102
Search in Google Scholar Back to article
19. Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, et al. Autoimmune gastritis. Nat Rev Dis Prim. 2020;6(1).10.1038/s41572-020-0187-832647173
Search in Google Scholar Back to article
20. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9.10.1111/j.1751-2980.2011.00550.x340460022188910
Search in Google Scholar Back to article
21. Correa P. Human Gastric Carcinogenesis: A Multistep and Multifactorial Process- First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52(24):6735–40.
Search in Google Scholar Back to article
22. Graham TA, McDonald SA, Wright NA. Field cancerization in the GI tract. Future Oncol.2021;7(8): 981–993.10.2217/fon.11.7021823893
Search in Google Scholar Back to article
23. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? The Lancet. 2001 Feb 17;357(9255):539-45.10.1016/S0140-6736(00)04046-011229684
Search in Google Scholar Back to article
24. Adamu MA, Weck MN, Rothenbacher D, Brenner H. Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow-up of a population-based cohort study. Int J Cancer. 2011;128(7):1652–8.10.1002/ijc.2547620503273
Search in Google Scholar Back to article
25. Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: Systematic review and meta-analysis. Gut. 2020;69(12):2113–21.10.1136/gutjnl-2020-32083932205420
Search in Google Scholar Back to article
26. Uemura N. H. pylori infection and the development of gastric cancer in Japan. Nihon rinsho.2003;61(1):25–9.
Search in Google Scholar Back to article
27. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer. 2004;109(1).10.1002/ijc.1168014735480
Search in Google Scholar Back to article

Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer

Abstract

Paradigm

My account